Evidence map›Paper›PMID 36680212›Full record

ArticleViruses2023

Measles Outbreak Response Activity in Japan, and a Discussion for a Possible Strategy of Outbreak Response Using Cycle Threshold Values of Real-Time Reverse Transcription PCR for Measles Virus in Measles Elimination Settings.

Junji Seto, Yoko Aoki, Kenichi Komabayashi, Keiko Yamada, Hitoshi Ishikawa, Tomoo Ichikawa, Tadayuki Ahiko, Katsumi Mizuta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Junji SetoYamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.ORCID 0000-0003-2227-5315
Yoko AokiYamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.
Kenichi KomabayashiYamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.
Keiko YamadaOkitama Public Health Center, Yamagata 992-0012, Japan.
Hitoshi IshikawaDepartment of Physical Therapy, Yamagata Prefectural University of Health Sciences, Yamagata 990-2212, Japan.
Tomoo IchikawaDepartment of Society and Regional Culture, Okinawa International University, Ginowan 901-2701, Japan.
Tadayuki AhikoYamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.
Katsumi MizutaYamagata Prefectural Institute of Public Health, Yamagata 990-0031, Japan.
Yamagata Prefectural Institute of Public Health · JPOkinawa International University · JPYamagata Prefectural Police · JPYamagata Prefectural University of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Measles is a highly contagious, but vaccine-preventable disease caused by the measles virus (MeV). Although the administration of two doses of measles vaccines is the most effective strategy to prevent and eliminate measles, MeV continues to spread worldwide, even in 2022. In measles-eliminated countries, preparedness and response to measles outbreaks originating from imported cases are required to maintain elimination status. Under these circumstances, real-time reverse transcription (RT) PCR for MeV could provide a diagnostic method capable of strengthening the subnational capacity for outbreak responses. Real-time RT-PCR can detect MeV RNA from patients with measles at the initial symptomatic stage, which can enable rapid public health responses aimed at detecting their contacts and common sources of infection. Furthermore, low cycle threshold (

Indexed as

MeaslesMeasles virusDisease OutbreaksHumansJapanMeasles VaccineReal-Time Polymerase Chain ReactionReverse TranscriptionMeasles Vaccinebreakthrough infectioneliminationmeasles virusnaïve infectionpreparednesspublic health responsereal-time reverse transcription PCRretrospective contact tracingsuper-spreadervaccination

Identifiers

PMID36680212
PMCPMC9863267
OpenAlexW4313891345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.